The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

Value-based care platform Signify Health is building out its offering for in-home testing and diagnostics, the company announced on Tuesday. The program, which is offered to Medicare Advantage and ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

First and only company with 100 approved and active companion diagnostic indications for next-generation sequencing in the ...

A major study investigating the diagnosis and outcomes of more than 400,000 people with heart failure over the past 20 years ...

A car can be compared to the human body and may need diagnostic tests very often. For humans, when a patient consults a doctor about a symptom, the doctor runs a medical diagnostic test to ascertain ...

Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have ...

R.R. Donnelley & Sons Company (RRD), a leading global provider of marketing, packaging, print, and supply chain solutions, announced the extended portfolio of end-to-end services to support at-home ...

London, Ontario: Dr. John McNaught, FRCSC, OB/GYN, MD and his teams at CReATe Fertility and London Women’s Health Care are ...

The IDEXX Cancer Dx is a new blood-based screening/diagnostic panel aimed at detecting canine lymphoma from serum or whole ...